The vascular closure devices market size has grown strongly in recent years. It will grow from $1.62 billion in 2025 to $1.73 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to rise in cardiac catheterization and angioplasty procedures, increasing reliance on femoral access interventions, growing hospital adoption of suture based and mechanical closure devices, focus on reducing manual compression time and recovery duration, rising awareness of post procedural bleeding risks.
The vascular closure devices market size is expected to see strong growth in the next few years. It will grow to $2.31 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to shift toward radial access approaches in cath labs, increasing utilization of external hemostatic and adjustable compression devices, expanding interventional cardiology capacity in emerging markets, rising investments in access site safety and complication reduction, growing preference for minimally invasive closure technologies. Major trends in the forecast period include increasing adoption of vascular closure devices to reduce post-catheterization complications, rising demand for closure systems that minimize bleeding and hematoma formation, growing procedural volumes in interventional cardiology and angiography requiring reliable access site sealing, expanding clinical shift toward faster patient ambulation and reduced hospital stay durations, increasing preference for closure devices that enhance workflow efficiency and patient safety.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the vascular closure devices market. Cardiovascular disease (CVD) encompasses conditions affecting the heart or blood vessels, which can impair blood flow to the heart. Vascular closure devices (VCDs) serve as alternatives to conventional mechanical compression, providing rapid sealing of femoral artery access sites. This can result in faster hemostasis and a lower risk of bleeding or hemorrhage following procedures. For instance, in January 2024, according to the American Heart Association, a US-based non-profit, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, up 4% from 224.4 per 100,000 in 2023. Therefore, the rising prevalence of cardiovascular diseases is expected to propel the vascular closure devices market.
The growing prevalence of obesity is also driving market expansion. Obesity is a medical condition characterized by excess body fat that negatively impacts health and arises from an imbalance between calories consumed and calories expended. Vascular closure devices are particularly useful for overweight and obese patients, helping to reduce bleeding risks and manage procedural challenges associated with anatomical factors and excess adipose tissue. For example, in March 2023, the World Heart Foundation, a Switzerland-based global cardiovascular organization, reported that approximately 2.3 billion adults and children were obese or overweight worldwide, with projections suggesting this number could reach 2.7 billion by 2025.
Companies in the market are developing advanced technologies to enhance patient outcomes and procedural efficiency. One such innovation is collapsible disc technology, which allows a disc to be easily collapsed and expanded for efficient use during vascular procedures. For instance, in June 2024, Haemonetics Corporation, a US-based medical technology company, launched the VASCADE MVP XL, a mid-bore vascular closure device. The VASCADE MVP XL incorporates 58% more collagen and a larger disc than its predecessor, providing a more robust closure solution, faster recovery, and improved patient outcomes.
Major companies operating in the vascular closure devices market are Abbott Laboratories, Terumo Corporation, Teleflex Incorporated, Haemonetics Corporation, Vasorum Ltd, INVAMED Inc, Vivasure Medical Ltd, Merit Medical Systems Inc, Rex Medical, Transluminal Technologies LLC, Tricol Biomedical Inc, Essential Medical Inc, InSeal Medical Ltd, Meril Life Sciences Pvt Ltd, Forge Medical, Vascular Closure Systems Ltd, Aachen Resonance GmbH, LeMaitre Vascular, Acandis GmbH, MiCroPort Scientific Co Ltd.
North America was the largest region in the vascular closure devices market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the vascular closure devices market by increasing the import costs of polymers, biomaterials, sutures, mechanical components, and precision molding parts used in passive and active approximators and external hemostatic devices, resulting in higher manufacturing and procurement prices for hospitals and acute care facilities. The impact is more pronounced in femoral access closure systems and high-value mechanical approximators across North America, Europe, and Asia-Pacific markets with globalized supply chains. However, tariffs are also driving localization of production, regional assembly, and alternative sourcing strategies, which in turn encourage cost optimization and product innovation to strengthen long-term market resilience.
The vascular closure devices market research report is one of a series of new reports that provides vascular closure devices market statistics, including vascular closure devices industry global market size, regional shares, competitors with a vascular closure devices market share, detailed vascular closure devices market segments, market trends and opportunities, and any further data you may need to thrive in the vascular closure devices industry. This vascular closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vascular closure devices are medical devices designed to seal the entry point in an artery following a catheterization procedure, minimizing the risk of complications such as bleeding or hematoma formation. These devices accelerate the natural healing process at the access site.
The primary categories of vascular closure devices include passive approximators, active approximators, and external hemostatic devices. Passive approximators involve the use of plugs, sealants, or gels at the arteriotomy site without physically closing the arteriotomy. These devices are utilized for femoral and radial access procedures and find applications in acute care facilities, hospitals, clinics, and other healthcare settings.
The vascular closure devices market consists of sales of clip-based devices, suture-based devices, plug-based devices, and compression devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The vascular closure devices market size is expected to see strong growth in the next few years. It will grow to $2.31 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to shift toward radial access approaches in cath labs, increasing utilization of external hemostatic and adjustable compression devices, expanding interventional cardiology capacity in emerging markets, rising investments in access site safety and complication reduction, growing preference for minimally invasive closure technologies. Major trends in the forecast period include increasing adoption of vascular closure devices to reduce post-catheterization complications, rising demand for closure systems that minimize bleeding and hematoma formation, growing procedural volumes in interventional cardiology and angiography requiring reliable access site sealing, expanding clinical shift toward faster patient ambulation and reduced hospital stay durations, increasing preference for closure devices that enhance workflow efficiency and patient safety.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the vascular closure devices market. Cardiovascular disease (CVD) encompasses conditions affecting the heart or blood vessels, which can impair blood flow to the heart. Vascular closure devices (VCDs) serve as alternatives to conventional mechanical compression, providing rapid sealing of femoral artery access sites. This can result in faster hemostasis and a lower risk of bleeding or hemorrhage following procedures. For instance, in January 2024, according to the American Heart Association, a US-based non-profit, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, up 4% from 224.4 per 100,000 in 2023. Therefore, the rising prevalence of cardiovascular diseases is expected to propel the vascular closure devices market.
The growing prevalence of obesity is also driving market expansion. Obesity is a medical condition characterized by excess body fat that negatively impacts health and arises from an imbalance between calories consumed and calories expended. Vascular closure devices are particularly useful for overweight and obese patients, helping to reduce bleeding risks and manage procedural challenges associated with anatomical factors and excess adipose tissue. For example, in March 2023, the World Heart Foundation, a Switzerland-based global cardiovascular organization, reported that approximately 2.3 billion adults and children were obese or overweight worldwide, with projections suggesting this number could reach 2.7 billion by 2025.
Companies in the market are developing advanced technologies to enhance patient outcomes and procedural efficiency. One such innovation is collapsible disc technology, which allows a disc to be easily collapsed and expanded for efficient use during vascular procedures. For instance, in June 2024, Haemonetics Corporation, a US-based medical technology company, launched the VASCADE MVP XL, a mid-bore vascular closure device. The VASCADE MVP XL incorporates 58% more collagen and a larger disc than its predecessor, providing a more robust closure solution, faster recovery, and improved patient outcomes.
Major companies operating in the vascular closure devices market are Abbott Laboratories, Terumo Corporation, Teleflex Incorporated, Haemonetics Corporation, Vasorum Ltd, INVAMED Inc, Vivasure Medical Ltd, Merit Medical Systems Inc, Rex Medical, Transluminal Technologies LLC, Tricol Biomedical Inc, Essential Medical Inc, InSeal Medical Ltd, Meril Life Sciences Pvt Ltd, Forge Medical, Vascular Closure Systems Ltd, Aachen Resonance GmbH, LeMaitre Vascular, Acandis GmbH, MiCroPort Scientific Co Ltd.
North America was the largest region in the vascular closure devices market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the vascular closure devices market by increasing the import costs of polymers, biomaterials, sutures, mechanical components, and precision molding parts used in passive and active approximators and external hemostatic devices, resulting in higher manufacturing and procurement prices for hospitals and acute care facilities. The impact is more pronounced in femoral access closure systems and high-value mechanical approximators across North America, Europe, and Asia-Pacific markets with globalized supply chains. However, tariffs are also driving localization of production, regional assembly, and alternative sourcing strategies, which in turn encourage cost optimization and product innovation to strengthen long-term market resilience.
The vascular closure devices market research report is one of a series of new reports that provides vascular closure devices market statistics, including vascular closure devices industry global market size, regional shares, competitors with a vascular closure devices market share, detailed vascular closure devices market segments, market trends and opportunities, and any further data you may need to thrive in the vascular closure devices industry. This vascular closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vascular closure devices are medical devices designed to seal the entry point in an artery following a catheterization procedure, minimizing the risk of complications such as bleeding or hematoma formation. These devices accelerate the natural healing process at the access site.
The primary categories of vascular closure devices include passive approximators, active approximators, and external hemostatic devices. Passive approximators involve the use of plugs, sealants, or gels at the arteriotomy site without physically closing the arteriotomy. These devices are utilized for femoral and radial access procedures and find applications in acute care facilities, hospitals, clinics, and other healthcare settings.
The vascular closure devices market consists of sales of clip-based devices, suture-based devices, plug-based devices, and compression devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Vascular Closure Devices Market Characteristics
3. Vascular Closure Devices Market Supply Chain Analysis
4. Global Vascular Closure Devices Market Trends and Strategies
5. Vascular Closure Devices Market Analysis of End Use Industries
7. Global Vascular Closure Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Vascular Closure Devices Total Addressable Market (TAM) Analysis for the Market
9. Vascular Closure Devices Market Segmentation
10. Vascular Closure Devices Market Regional and Country Analysis
11. Asia-Pacific Vascular Closure Devices Market
12. China Vascular Closure Devices Market
13. India Vascular Closure Devices Market
14. Japan Vascular Closure Devices Market
15. Australia Vascular Closure Devices Market
16. Indonesia Vascular Closure Devices Market
17. South Korea Vascular Closure Devices Market
18. Taiwan Vascular Closure Devices Market
19. South East Asia Vascular Closure Devices Market
20. Western Europe Vascular Closure Devices Market
21. UK Vascular Closure Devices Market
22. Germany Vascular Closure Devices Market
23. France Vascular Closure Devices Market
24. Italy Vascular Closure Devices Market
25. Spain Vascular Closure Devices Market
26. Eastern Europe Vascular Closure Devices Market
27. Russia Vascular Closure Devices Market
28. North America Vascular Closure Devices Market
29. USA Vascular Closure Devices Market
30. Canada Vascular Closure Devices Market
31. South America Vascular Closure Devices Market
32. Brazil Vascular Closure Devices Market
33. Middle East Vascular Closure Devices Market
34. Africa Vascular Closure Devices Market
36. Vascular Closure Devices Market Competitive Landscape and Company Profiles
37. Vascular Closure Devices Market Other Major and Innovative Companies
40. Vascular Closure Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Vascular Closure Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses vascular closure devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for vascular closure devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vascular closure devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Passive Approximators; Active Approximators; External Hemostatic Devices2) By Access: Femoral Access; Radial Access
3) By End User: Acute Care Facilities; Hospitals; Clinics; Other End Users
Subsegments:
1) By Passive Approximators: Suture-Based Devices; Fibrin Sealants2) By Active Approximators: Mechanical Devices; Expanding Devices
3) By External Hemostatic Devices: Compression Bandages; Adjustable Hemostatic Devices
Companies Mentioned: Abbott Laboratories; Terumo Corporation; Teleflex Incorporated; Haemonetics Corporation; Vasorum Ltd; INVAMED Inc; Vivasure Medical Ltd; Merit Medical Systems Inc; Rex Medical; Transluminal Technologies LLC; Tricol Biomedical Inc; Essential Medical Inc; InSeal Medical Ltd; Meril Life Sciences Pvt Ltd; Forge Medical; Vascular Closure Systems Ltd; Aachen Resonance GmbH; LeMaitre Vascular; Acandis GmbH; MiCroPort Scientific Co Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Vascular Closure Devices market report include:- Abbott Laboratories
- Terumo Corporation
- Teleflex Incorporated
- Haemonetics Corporation
- Vasorum Ltd
- INVAMED Inc
- Vivasure Medical Ltd
- Merit Medical Systems Inc
- Rex Medical
- Transluminal Technologies LLC
- Tricol Biomedical Inc
- Essential Medical Inc
- InSeal Medical Ltd
- Meril Life Sciences Pvt Ltd
- Forge Medical
- Vascular Closure Systems Ltd
- Aachen Resonance GmbH
- LeMaitre Vascular
- Acandis GmbH
- MiCroPort Scientific Co Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.73 Billion |
| Forecasted Market Value ( USD | $ 2.31 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
